Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Soodeh Razeghi Jahromi, Fahimeh Martami, Kasra Morad Soltani & Mansoureh Togha. (2023) Migraine and obesity: what is the real direction of their association?. Expert Review of Neurotherapeutics 23:1, pages 75-84.
Read now
Read now
Luana Lionetto, Barbara Casolla, Fabiola Mastropietri, Lidia D'Alonzo, Andrea Negro, Maurizio Simmaco & Paolo Martelletti. (2012) Pharmacokinetic evaluation of zolmitriptan for the treatment of migraines. Expert Opinion on Drug Metabolism & Toxicology 8:8, pages 1043-1050.
Read now
Read now
Michael JM Fischer. (2010) Calcitonin gene-related peptide receptor antagonists for migraine. Expert Opinion on Investigational Drugs 19:7, pages 815-823.
Read now
Read now
Articles from other publishers (28)
Mai Ahmed Tawfik, Mai M. Eltaweel, Ahmed M. Fatouh, Hesham A. Shamsel-Din & Ahmed B. Ibrahim. (2023) Brain targeting of zolmitriptan via transdermal terpesomes: statistical optimization and in vivo biodistribution study by 99mTc radiolabeling technique. Drug Delivery and Translational Research 13:12, pages 3059-3076.
Crossref
Crossref
A. V. Amelin, I. S. Vaganova, M. I. Koreshkina & N. M. Tereshchenko. (2023) Efficacy of zolmitriptan nasal spray in adult patients with migraine. Meditsinskiy sovet = Medical Council:13, pages 65-71.
Crossref
Crossref
Mikael Thomsen, Anca Stoica, Kenneth Vielsted Christensen, Tue Fryland, Jens D. Mikkelsen & John Bondo Hansen. (2022) Synergistic effect of serotonin 1A and serotonin 1B/D receptor agonists in the treatment of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats. Experimental Neurology 358, pages 114209.
Crossref
Crossref
Mai M. El Taweel, Mona H. Aboul-Einien, Mohammed A. Kassem & Nermeen A. Elkasabgy. (2021) Intranasal Zolmitriptan-Loaded Bilosomes with Extended Nasal Mucociliary Transit Time for Direct Nose to Brain Delivery. Pharmaceutics 13:11, pages 1828.
Crossref
Crossref
Raul Garcia, Tien Le, Samantha N. Scott, Delaram Charmchi, Jamie M.L. Sprout, Nathan S. Pentkowski & Janet L. Neisewander. (2020) Preclinical support for the therapeutic potential of zolmitriptan as a treatment for cocaine use disorders. Translational Psychiatry 10:1.
Crossref
Crossref
Marloes A. M. Peters, Coby Meijer, Rudolf S. N. Fehrmann, Annemiek M. E. Walenkamp, Ido P. Kema, Elisabeth G. E. de Vries, Harry Hollema & Sjoukje F. Oosting. (2019) Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare Cancers. Pathology & Oncology Research 26:3, pages 1539-1547.
Crossref
Crossref
Satyendra Deka, Ratnali Bania, Pobitra Borah, Sanjib Das & Pran Kishore Deb. 2020. Frontiers in Pharmacology of Neurotransmitters. Frontiers in Pharmacology of Neurotransmitters
183
212
.
Puneet Kumar, Sara Nidal Abed, Yazan A. Bataineh & Mutaz Sheikh Salem. 2020. Frontiers in Pharmacology of Neurotransmitters. Frontiers in Pharmacology of Neurotransmitters
1
29
.
Tal Eidlitz Markus & Irene Toldo. (2018) Obesity and Migraine in Childhood. Current Pain and Headache Reports 22:6.
Crossref
Crossref
Ahmed S. Saad, Mohamed R. El-Ghobashy, Nada S. Ayish & Badr A. El-Zeany. (2018)
ISE-potentiometric sensor for the determination of zolmitriptan: applications in plasma, pharmaceutical formulation and
in vitro
release profile
. New Journal of Chemistry 42:18, pages 15263-15269.
Crossref
Crossref
G. Farello, P. Ferrara, A. Antenucci, C. Basti & A. Verrotti. (2017) The link between obesity and migraine in childhood: a systematic review. Italian Journal of Pediatrics 43:1.
Crossref
Crossref
Claudia Francesca Gasparini, Robert Anthony Smith & Lyn Robyn Griffiths. (2017) Genetic and biochemical changes of the serotonergic system in migraine pathobiology. The Journal of Headache and Pain 18:1.
Crossref
Crossref
Tal Eidlitz-Markus & Irene Toldo. 2017. Headache and Comorbidities in Childhood and Adolescence. Headache and Comorbidities in Childhood and Adolescence
173
183
.
Cindy N. Chai, B. Lee Peterlin, Ann I. Scher & Simona Sacco. 2017. Comorbidities in Headache Disorders. Comorbidities in Headache Disorders
121
147
.
Priyoneel Basu, Naomi Ie, Adrienne L. Wensel, Joelle D. Baskerville, Victoria M. Smith & Michael C. Antle. (2015) Triptans attenuate circadian responses to light. European Journal of Neuroscience 42:7, pages 2489-2495.
Crossref
Crossref
Saskia van Hemert, Anne C. Breedveld, Jörgen M. P. Rovers, Jan P. W. Vermeiden, Ben J. M. Witteman, Marcel G. Smits & Nicole M. de Roos. (2014) Migraine Associated with Gastrointestinal Disorders: Review of the Literature and Clinical Implications. Frontiers in Neurology 5.
Crossref
Crossref
Nu Cindy Chai, Dale S. Bond, Abhay Moghekar, Ann I. Scher & B. Lee Peterlin. (2014) Obesity and Headache: Part II - Potential Mechanism and Treatment Considerations. Headache: The Journal of Head and Face Pain 54:3, pages 459-471.
Crossref
Crossref
Stewart J. Tepper, Susy Chen, Faith Reidenbach & Alan M. Rapoport. (2013) Intranasal Zolmitriptan for the Treatment of Acute Migraine. Headache: The Journal of Head and Face Pain 53:S2, pages 62-71.
Crossref
Crossref
P. K Arora, A. Chauhan, D Duggal, P. K., Saini, S. C Mathur, R M. Singh & G. N Singh. (2013) DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE DETERMINATION OF ZOLMITRIPTAN IN BULK DRUG AND TABLET DOSAGE FORM. INDIAN DRUGS 50:08, pages 20-26.
Crossref
Crossref
J. M. D'Amico, Y. Li, D. J. Bennett & M. A. Gorassini. (2012) Reduction of spinal sensory transmission by facilitation of 5-HT1B/D receptors in noninjured and spinal cord-injured humans. Journal of Neurophysiology 109:6, pages 1485-1493.
Crossref
Crossref
Saurabh Gupta, Stephanie J. Nahas & B. Lee Peterlin. (2011) Chemical Mediators of Migraine: Preclinical and Clinical Observations. Headache: The Journal of Head and Face Pain 51:6, pages 1029-1045.
Crossref
Crossref
&NA;. (2011) Key differences between triptans relate to their pharmacokinetic profiles and available formulations. Drugs & Therapy Perspectives 27:3, pages 15-18.
Crossref
Crossref
Jan D. Andersson, M. Edward Pierson, Sjoerd J. Finnema, Balázs Gulyás, Richard Heys, Charles S. Elmore, Lars Farde & Christer Halldin. (2011) Development of a PET radioligand for the central 5-HT1B receptor: radiosynthesis and characterization in cynomolgus monkeys of eight radiolabeled compounds. Nuclear Medicine and Biology 38:2, pages 261-272.
Crossref
Crossref
Debra Elliott, Xiangping Li, Peimin Zhu & Emil Gaitour. 2011. Neurological Disorders and Pregnancy. Neurological Disorders and Pregnancy
13
54
.
Mollie M. Johnston & Alan M. Rapoport. (2010) Triptans for the Management of Migraine. Drugs 70:12, pages 1505-1518.
Crossref
Crossref
Joshua L. Gowin, Alan C. Swann, F. Gerard Moeller & Scott D. Lane. (2010) Zolmitriptan and human aggression: interaction with alcohol. Psychopharmacology 210:4, pages 521-531.
Crossref
Crossref
B. Lee Peterlin, Alan M. Rapoport & Tobias Kurth. (2010) Migraine and Obesity: Epidemiology, Mechanisms, and Implications. Headache: The Journal of Head and Face Pain 50:4, pages 631-648.
Crossref
Crossref
A.A. KalanuriaB.L. Peterlin. (2009) A Review of the Pharmacokinetics, Pharmacodynamics and Efficacy of Zolmitriptan in the Acute Abortive Treatment of Migraine. Clinical Medicine. Therapeutics 1, pages CMT.S2056.
Crossref
Crossref